Patent details

EN | LT

LT - GENES AND GENES COMBINATIONS BASED ON GENE MKNK1 PREDICTIVE OF EARLY RESPONSE OR NON RESPONSE OF SUBJECTS SUFFERING FROM RHEUMATOID ARTHRITIS TO TNF-ALPHA BLOCKING MONOCLONAL ANTIBODY

EN - GENES AND GENES COMBINATIONS BASED ON GENE MKNK1 PREDICTIVE OF EARLY RESPONSE OR NON RESPONSE OF SUBJECTS SUFFERING FROM RHEUMATOID ARTHRITIS TO TNF-ALPHA BLOCKING MONOCLONAL ANTIBODY

Legal status

Patent not validated

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C12Q 1/68

European patent
(11)	Number of the document	2668287
(13)	Kind of document	T
(96)	European patent application number	12700864.7
	Date of filing the European patent application	2012-01-25
(97)	Date of publication of the European application	2013-12-04
(45)	Date of publication and mention of the grant of the patent	2017-09-06
(46)	Date of publication of the claims translation

PCT application
(86)	Number	PCT/EP2012/051164
	Date	2012-01-25

PCT application publication
(87)	Number	WO 2012/101183
	Date	2012-08-02

Priority applications
(30)	Number	Date	Country code
	201161457191 P	2011-01-25	US
	201161457743 P	2011-05-25	US
	201261588390 P	2012-01-19	US

Inventors
(72)	CERVINO, Alessandra, FR POPA-NITA, Oana, FR PLASSAIS, Jonathan, FR

Grantee
(73)	TC LAND Expression, 21, rue de la Noue Bras de Fer Bio Ouest Ile de Nantes, 44200 Nantes, FR

Title
(54)	GENES AND GENES COMBINATIONS BASED ON GENE MKNK1 PREDICTIVE OF EARLY RESPONSE OR NON RESPONSE OF SUBJECTS SUFFERING FROM RHEUMATOID ARTHRITIS TO TNF-ALPHA BLOCKING MONOCLONAL ANTIBODY
	GENES AND GENES COMBINATIONS BASED ON GENE MKNK1 PREDICTIVE OF EARLY RESPONSE OR NON RESPONSE OF SUBJECTS SUFFERING FROM RHEUMATOID ARTHRITIS TO TNF-ALPHA BLOCKING MONOCLONAL ANTIBODY